This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: T31.7 (Burns involving 70-79% of body surface) | Special Copayment Reduction: V248 (Special Copayment Reduction for severe burns, category 2: condition of 30% or more of body surface area or including third-degree burns; 5% copayment for 1 year from the registration date) |
| B. Synonyms | Ultra-extensive full-thickness burn, ultra-major full-thickness burn 70–79%, lethal burn zone (70–79% BSA), lethal full-thickness burn |
| C. Adult onset | Full-thickness burns of 70–79% TBSA are almost always fatal in middle-aged and elderly patients (mortality 55–80%) and are an extreme injury that is survivable even in young and middle-aged adults only with state-of-the-art treatment at a specialized burn center. |
| 1. History | Describes the course of development from the first historical reports of survival in burns of 70% TBSA or more to modern advanced treatment. |
| 2. Causes | Explains the characteristics and circumstances of the extreme fires, explosions, and electrical accidents that cause burns of 70% TBSA or more. |
| 3. Genetics | Covers the mechanisms by which gene polymorphisms determine survival or death in extreme burn injury of 70% or more. |
| 4. General epidemiology | Analyzes the incidence, mortality, age distribution of survival, and rate of concomitant inhalation injury in burns of 70–79% TBSA. |
| 5. Pathophysiology | Explains in detail the total collapse of physiological systems due to loss of 3/4 of the skin, extreme hypermetabolism, immunoparalysis, and the cascade of multiple organ dysfunction. |
| 6. Symptoms | Describes extensive insensate eschar, lethal burn shock, extreme inhalation injury, and symptoms of MODS. |
| 7. Signs | Includes full-thickness eschar over the whole body, signs of severe multiple organ dysfunction, DIC, ARDS, and signs of intestinal failure. |
| 8. Screening | Includes TBSA estimation and screening for multiple organ dysfunction, DIC, abdominal compartment syndrome, ARDS, and CO poisoning. |
| 9. Diagnosis | Includes intensive multisystem monitoring, evaluation of ECMO indications, and criteria for transition to palliative care. |
| 10. Treatment | Describes extreme fluid resuscitation, combined skin substitute strategies, ECMO, suppression of severe hypermetabolism, infection and nutrition management, and a palliative approach. |
| 11. Prognosis | Discusses overall mortality of 55–80%, revised Baux score of 110–160, and extreme long-term complications and quality of life in survivors. |
| 12. Prevention | Systematically describes individual, industrial, institutional, and public health prevention strategies for preventing extreme burns. |
| 13. References | Herndon DN, et al. Support of the metabolic response to burn injury. Lancet. 2004 … and 9 other papers |
Full-thickness burns involving 70–79% of body surface area were almost without exception fatal before the advances of modern medicine. Until the early 20th century, most burn patients in this range died of burn shock within 24–72 hours, and because there were no survivors at all, serious attempts at treatment were hardly ever made. Even in the 1940s–50s, it was common for patients with burns of 70% or more of body surface area to receive only palliative care.
The turning point came in two stages. The first was the fluid resuscitation revolution of the 1960s–70s, when the introduction of the Parkland formula (1968) made it possible for the first time to manage burn shock systematically. As a result, some patients with burns of 70% TBSA or more were able to survive beyond the initial shock phase, and survival gradually improved with subsequent advances in early excision and grafting techniques and critical care medicine. The establishment of the concept of early excision and grafting by Burke et al. in 1974 and the development of cultured epidermal autograft (CEA) technology in 1981 brought revolutionary changes to the treatment of burns in this range.
The second stage was the advance of hypermetabolism research and molecular medicine in the 1990s–2000s. Through systematic research on pediatric burn patients at Shriners Hospital for Children, Herndon et al. elucidated the mechanisms of the hypermetabolic response and developed a hypermetabolism suppression protocol combining propranolol, oxandrolone, growth hormone, and insulin, presenting a way to suppress muscle wasting and preserve immune function. In addition, the study by Kraft et al. published in Lancet in 2012 showed the possibility of survival in children even at 100% or more TBSA (an expression accounting for overlapping burns), shocking the world medical community. In the 21st century, advanced technologies such as ECMO for burns, stem cell-derived skin, and 3D bioprinted skin are being researched and applied, and at specialized burn centers a survival rate of 20–40% can be expected for young and middle-aged adults with full-thickness burns of 70–79% TBSA.
Full-thickness burns involving 70–79% of body surface area are an extreme injury in which an area corresponding to three-quarters of the body is affected, occurring in situations of an entirely different order from ordinary burn accidents. Among the main causes, entrapment in major fire is the most common. Most of the body is exposed to flames in situations such as escape being blocked by building collapse, inability to escape a vehicle fire, or being surrounded by a wildfire.
Catastrophic explosions occur in gas storage tank explosions, military and industrial explosive accidents, and terrorist bombings, with explosive flames covering the body extensively. In these cases, inhalation injury, blast injury, and penetrating injuries from fragments occur in combination. Prolonged exposure to burning clothing or bedding occurs in people with alcoholism, those in a state of loss of consciousness (drugs, seizures, stroke), and elderly people with impaired mobility, and loss of the ability to escape is the decisive cause of extensive burns. Massive chemical exposure occurs when highly ignitable chemicals cover the entire body in chemical plant explosions or leaks, combining skin burns with inhaled chemical injury and systemic toxicity. Arson, war injuries (napalm, white phosphorus), and suicide attempts (self-immolation) can also cause burns in this range.
In extreme burn injury reaching 70–79% of body surface area, genetic factors are key variables determining biological resilience and vulnerability. Clinical courses can differ markedly even between two people with the same injury, and a considerable part of these individual differences is attributable to genetic background.
In recent genome-wide association studies (GWAS) of large burn cohorts, several single nucleotide polymorphisms (SNPs) associated with the development of sepsis after burns have been found, distributed in genes related to innate immune receptors (TLR2, TLR4, TLR9), intracellular signaling pathways (MyD88, IRAK4, TRIF), and antimicrobial peptides (defensin). Mitochondrial DNA (mtDNA) polymorphisms affect cellular energy metabolism and oxidative stress responses, creating individual differences in the capacity to cope with the extreme energy demands and oxidative load of burns of 70% or more.
Polymorphisms in NLRP3 inflammasome-related genes regulate the production of IL-1β and IL-18, determining the intensity of the excessive inflammatory response after burns. Overactivation of this pathway is an important mechanism of septic shock and multiple organ dysfunction. Epigenetic changes also play an important role; recent studies report that within a few days after a burn, DNA methylation patterns of immune-related genes change rapidly, inducing immunoparalysis. This genetic and epigenetic understanding may become the basis for personalized burn treatment in the future.
Full-thickness burns involving 70–79% of body surface area are very rare, accounting for less than 0.3–0.5% of all burn admissions, but they are an extremely high-mortality injury group accounting for 30–40% of burn-related deaths. In the US burn database, the average intensive care unit length of stay for patients in this range is 120–180 days, and transfusion volume reaches 100–150 units.
The difference in mortality by age is most pronounced in this range. Whereas survival with treatment at specialized burn centers reaches 25–40% in young adult patients in their 20s–30s, it is 10–25% in those in their 40s–50s, less than 5% in those aged 60 and older, and survival is extremely rare in those aged 70 and older. In children, burns in this range also have a very poor prognosis, but survival of 40–50% has been reported in adolescents (aged 10–18). The rate of concomitant inhalation injury reaches 70–80% in burns of 70% TBSA or more, and mortality is more than twice as high compared with cases without inhalation injury.
The temporal distribution of deaths shows a trimodal pattern. 1) Early (1–72 hours): burn shock, airway obstruction, and carbon monoxide poisoning are the main causes of death. 2) Intermediate (1–3 weeks): sepsis and multiple organ dysfunction are the main causes of death. 3) Late (3–12 weeks): recurrent infection, nutritional failure, and complications related to mechanical ventilation are the main causes of death. Survival for burns in this range has steadily improved over the last 10–20 years, but it remains one of the most difficult clinical challenges facing modern medicine.
Full-thickness burns of 70–79% of body surface area destroy more than three-quarters of the skin, the largest organ of the human body, which means a total collapse of the system that maintains bodily homeostasis. Heat-induced protein denaturation and coagulation necrosis occur through the full thickness, from the epidermis to the subcutaneous fat and in some cases to the fascia. Complete destruction of nerve endings causes loss of pain sensation, and all skin appendage structures such as sweat glands, hair follicles, and sebaceous glands are lost.
The pathophysiology immediately after injury consists of two simultaneous processes. First, burn shock: extensive vascular endothelial damage causes massive leakage of plasma proteins and fluid, resulting in hypovolemic shock. In burns of 70% TBSA or more, the fluid requirement in the first 24 hours can exceed 20,000 mL. Second, inhalation injury: it accompanies 70–80% of patients with burns of 70% TBSA or more, and upper airway edema, bronchospasm, and chemical lung injury occur in combination, making airway securing and maintenance of respiration extremely difficult.
In the extreme hypermetabolic state beginning 3–5 days after the burn, the basal metabolic rate reaches 200–250% of normal, and severe catabolism due to sustained secretion of cortisol, catecholamines, and glucagon continues for months. Skeletal muscle wasting reaches 150–200 g per day, and without treatment, severe muscle weakness and impaired immune function develop within a few weeks. Bacterial translocation due to gut ischemia and increased permeability is a major cause of endogenous sepsis, forming a chain that leads to multiple organ dysfunction syndrome (MODS). In burns of 70% TBSA or more, AKI, ARDS, liver failure, and coagulopathy (DIC) occur almost inevitably, and when these organ failures progress simultaneously, mortality rises dramatically.
Patients with full-thickness burns of 70–79% of body surface area are in an extremely critical condition on arrival and may die within hours without immediate life-saving measures. Burn wound symptoms include complete loss of pain sensation in the full-thickness burn areas covering most of the body, and patients may complain of pain markedly less than their physical condition would suggest. However, there is severe pain in the remaining second-degree burn margins, and patients may show panic and extreme fear.
Systemic shock symptoms such as extreme hypotension (systolic blood pressure below 60 mmHg), tachycardia (>150/min), peripheral cyanosis, anuria, and decreased consciousness develop rapidly. With concomitant inhalation injury (present in 70–80%), hoarseness, inspiratory stridor, rapidly worsening dyspnea, and cyanosis demand immediate airway securing. Symptoms of carbon monoxide poisoning, such as clouded consciousness, headache, nausea, and coma, overlap with the burn injury. In burns of this range in particular, when inhalation injury and CO poisoning are both present, respiratory arrest can occur within minutes without airway securing.
After the initial resuscitation phase, fever (39–41°C), heavy sweating, tachycardia (120–150/min), and generalized wasting due to extreme hypermetabolism come to the fore. When sepsis complicates the course, changes in fever pattern, decreased consciousness, hypotension, and oliguria appear. As MODS progresses, jaundice (liver failure), anuria (renal failure), respiratory deterioration (ARDS), petechiae and bleeding (DIC), and coma (brain dysfunction) occur sequentially or simultaneously.
Physical signs in full-thickness burns of 70–79% of body surface area reflect a state of extreme systemic collapse. Wound signs include hard, leathery eschar covering more than three-quarters of the body. The eschar is pale white, tan, brown, or black, and in some cases charring is also seen. Capillary refill is completely absent, and there is no response at all to pinprick. On physical examination, it is clearly confirmed that skin contraction causes the eschar to compress the underlying tissue, cutting off limb blood flow and restricting chest movement.
Systemic vital signs such as extreme hypotension, severe tachycardia, hypothermia, and anuria reflect burn shock. In the peak edema phase after fluid resuscitation (24–72 hours), the whole body is extremely swollen, giving an appearance similar to an obese patient; abdominal distension is marked and intravesical pressure rises sharply. Because of airway edema, there is no air leak around the inserted endotracheal tube. Bilateral crackles and wheezes are heard on lung auscultation. Conjunctival and scleral edema is observed, and facial edema makes it impossible to open the eyes. Laboratory findings characteristically include severe metabolic acidosis (pH <7.2), hypoxemia, hypoalbuminemia (below 1.5 g/dL), thrombocytopenia (DIC), serum creatinine of 2–5 mg/dL or higher (acute renal failure), and elevated bilirubin (liver failure).
Initial screening of patients with burns of 70–79% of body surface area focuses on rapid identification of immediately life-threatening factors. TBSA estimation is done quickly with the rule of nines; in burns of this range, most of the body is a full-thickness burn, so relatively rapid estimation is possible. Determining the area of remaining normal skin is important for future autologous skin grafting plans.
For inhalation injury screening in this range, inhalation injury is in principle assumed to be present even without evidence, and immediate endotracheal intubation is prepared. Immediate intubation is performed when 4 or more of the criteria are present: facial and neck burns, loss of nasal hair, soot, hoarseness, and inspiratory stridor. For CO poisoning screening, arterial COHb measurement is essential. Abdominal compartment syndrome screening is by real-time monitoring of intravesical pressure. ARDS screening is by the PaO₂/FiO₂ ratio (ARDS criterion if <300 mmHg) and chest X-ray. For DIC screening, PT, aPTT, fibrinogen, D-dimer, and platelet count are measured immediately. Acute kidney injury screening is monitored with serum creatinine, hourly urine output, and urine myoglobin.
Diagnosis and monitoring of full-thickness burns of 70–79% of body surface area require the highest level of burn intensive care unit systems. An arterial catheter, central venous catheter, and indwelling urinary catheter are inserted immediately in all patients, and a pulmonary artery catheter or PiCCO is added if hemodynamics are unstable. Continuous electrocardiography, pulse oximetry, and end-tidal carbon dioxide (ETCO₂) monitoring are standard.
Laboratory tests, including ABG, CBC, BMP, LFT, albumin, a full set of coagulation tests, procalcitonin, CRP, CPK, blood lactate, and ScvO₂, are repeated at least 2–3 times/day. Bronchoscopy is performed immediately after intubation to assess the severity of inhalation injury, and subsequently bronchoalveolar lavage (BAL) is used to identify sources of infection. Chest X-ray is performed daily, and chest CT when evaluating pneumonia, pleural effusion, or worsening ARDS. Abdominal ultrasound evaluates intra-abdominal effusion, gallbladder function, and hepatic blood flow. If abdominal compartment syndrome is suspected, intravesical pressure is measured every 2–4 hours; 20 mmHg or higher requires immediate intervention, and 30 mmHg or higher requires emergency decompressive laparotomy. For evaluation of ECMO candidacy, the Murray lung injury score, persistent hypoxemia (PaO₂/FiO₂ <80 mmHg), and persistent pH <7.2 are considered as criteria.
Immediate endotracheal intubation is the top priority, and if intubation is difficult due to facial burns or edema, a surgical airway (emergency tracheostomy) is prepared. Mechanical ventilation is set according to a lung-protective strategy, and if ARDS develops, prone positioning, inhaled NO, high-frequency oscillatory ventilation, and extracorporeal membrane oxygenation (VV-ECMO) are applied in a stepwise manner.
Start with the Parkland formula (4 mL × kg × 75% TBSA, 21,000 mL in a 70 kg patient), titrating in real time with targets of urine output 0.5–1 mL/kg/hr, blood pressure, and normalization of blood lactate. To prevent abdominal compartment syndrome, a strategy of reducing fluid requirements with early albumin (5%) administration (from 6–12 hours after the burn) is applied. If intravesical pressure is 20 mmHg or higher, fluid volume is minimized and diuretics are considered; if 30 mmHg or higher, decompressive laparotomy is performed immediately.
Escharotomy of circumferential burns is performed as soon as hemodynamic stability is achieved, and staged excision and grafting begin as early as possible. Because autologous skin is absolutely insufficient, a multilayer strategy is used: ① cover the entire wound with Integra dermal regeneration template → ② STSG (autologous skin) grafting after 2–3 weeks → ③ cultured epidermal autograft (CEA) grafting → ④ temporary coverage with allograft skin. These steps are repeated to gradually achieve complete wound coverage. Mesh expansion (up to 1:6) is used to make maximum use of the limited autologous skin area.
Early tube feeding, high protein (3 g/kg/day or more), high calories (130% or more based on indirect calorimetry), and supplementation with glutamine, zinc, selenium, and vitamin C are provided. Propranolol (target 20% reduction in heart rate), oxandrolone (0.1 mg/kg/day), and recombinant growth hormone or IGF-1 are combined to suppress hypermetabolism and catabolism as much as possible. Glycemic control with insulin (100–140 mg/dL) is important for wound healing and maintaining immune function.
When the revised Baux score is 160 or higher or the patient and family do not wish to receive maximal treatment, the burn team should provide in-depth ethical counseling about transitioning to palliative care. In this case, care focuses on relief of pain and anxiety, maintaining dignity, and family support.
The prognosis of patients with full-thickness burns of 70–79% of body surface area is extremely poor even with modern medicine. Overall mortality reaches 55–80% even at specialized burn centers, and more than 90% of patients aged 60 and older die. By the revised Baux score (age + TBSA + 17 × inhalation injury), a 30-year-old patient with 75% TBSA in this range scores 105 without inhalation injury and 122 with concomitant inhalation injury, already falling in the poor-prognosis category. A 50-year-old patient with the same burn and concomitant inhalation injury scores 142, a level at which most specialized burn centers predict a mortality of 50% or more.
The most common causes of death are sepsis and multiple organ dysfunction, and most deaths occur 2–4 weeks after the burn. Even in surviving patients, extreme hypertrophic scarring, multiple joint contractures, severe functional impairment, chronic pain, sleep disturbance, PTSD, and depression seriously impair quality of life. Rehabilitation takes at least 2–5 years, and the return-to-work rate is very low at 15–30%. Secondary mortality within 5 years among survivors (long-term mortality) is also markedly higher than in the general population, so it should be recognized that surviving a burn is not a cure in the true sense but the beginning of a new chronic disease.
Prevention of lethal burns reaching 70–79% of body surface area realistically focuses on preventing fires and explosions and ensuring early escape. Because burns in this range occur not in ordinary accidents but in extreme situations, the role of disaster prevention at industrial sites and personal protective equipment is paramount. The highest level of protective clothing for firefighters and hazardous materials handlers (protective clothing meeting the NFPA 1975 standard, Level A HAZMAT protective suits) markedly reduces the occurrence of burns in this range.
At chemical and petroleum industry sites, leak detection systems, automatic shutoff valves, explosion-proof equipment, and securing safe zones reduce the occurrence of extensive burns due to large fires and explosions. In buildings, sprinkler systems, fire compartments, multiple emergency escape routes, and automatic fire alarm systems ensure escape time and prevent prolonged flame exposure. In war and military situations, personal fire-resistant clothing and implementation of the international convention banning incendiary weapons (Convention on Certain Conventional Weapons) are also important public health preventive measures. Individual fire risk assessments and tailored safety support programs for vulnerable groups (people with alcohol dependence, cognitive impairment, physical disabilities) are essential for preventing extensive burns in these groups.
Herndon DN, Tompkins RG. Support of the metabolic response to burn injury. Lancet. 2004;363(9424):1895–1902. DOI: 10.1016/S0140-6736(04)16360-5. PMID: 15183630.
Kraft R, Herndon DN, Al-Mousawi AM, Williams FN, Finnerty CC, Jeschke MG. Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study. Lancet. 2012;379(9820):1013–1021. DOI: 10.1016/S0140-6736(11)61345-7. PMID: 22296810.
Jeschke MG, van Baar ME, Choudhry MA, Chung KK, Gibran NS, Logsetty S. Burn injury. Nat Rev Dis Primers. 2020;6(1):11. DOI: 10.1038/s41572-020-0145-5. PMID: 32054846.
Osler T, Glance LG, Hosmer DW. Simplified estimates of the probability of death after burn injuries: extending and updating the baux score. J Trauma. 2010;68(3):690–697. DOI: 10.1097/TA.0b013e3181c453b3. PMID: 20220426.
Greenhalgh DG. Management of burns. N Engl J Med. 2019;380(24):2349–2359. DOI: 10.1056/NEJMra1807442. PMID: 31189038.
Pham TN, Cancio LC, Gibran NS; American Burn Association. American Burn Association practice guidelines burn shock resuscitation. J Burn Care Res. 2008;29(1):257–266. DOI: 10.1097/BCR.0b013e31815f3876. PMID: 18182930.
Brusselaers N, Monstrey S, Vogelaers D, Hoste E, Blot S. Severe burn injury in Europe: a systematic review of the incidence, etiology, morbidity, and mortality. Crit Care. 2010;14(5):R188. DOI: 10.1186/cc9300. PMID: 20958963.
Church D, Elsayed S, Reid O, Winston B, Lindsay R. Burn wound infections. Clin Microbiol Rev. 2006;19(2):403–434. DOI: 10.1128/CMR.19.2.403-434.2006. PMID: 16614255.
Williams FN, Herndon DN, Jeschke MG. The hypermetabolic response to burn injury and interventions to modify this response. Clin Plast Surg. 2009;36(4):583–596. DOI: 10.1016/j.cps.2009.05.001. PMID: 19793551.
Rousseau AF, Losser MR, Ichai C, Berger MM. ESPEN endorsed recommendations: nutritional therapy in major burns. Clin Nutr. 2013;32(4):497–502. DOI: 10.1016/j.clnu.2013.02.012. PMID: 23582468.